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Abstract
Objective To assess whether anthropometrics, clinical risk factors, and coronary artery calcium score (CACS) can predict the
need of further testing after coronary CT angiography (CTA) due to non-diagnostic image quality and/or the presence of
significant stenosis.
Methods Consecutive patients who underwent coronary CTA due to suspected coronary artery disease (CAD) were included in our
retrospective analysis. We used multivariate logistic regression and receiver operating characteristics analysis containing anthropomet-
ric factors: body mass index, heart rate, and rhythm irregularity (model 1); and parameters used for pre-test likelihood estimation: age,
sex, and type of angina (model 2); and also added total calcium score (model 3) to predict downstream testing.
Results We analyzed 4120 (45.7% female, 57.9 ± 12.1 years) patients. Model 3 significantly outperformed models 1 and 2 (area
under the curve, 0.84 [95% CI 0.83–0.86] vs. 0.56 [95% CI 0.54–0.58] and 0.72 [95% CI 0.70–0.74], p < 0.001). For patients
with sinus rhythm of 50 bpm, in case of non-specific angina, CACS above 435, 756, and 944; in atypical angina CACS above
381, 702, and 890; and in typical angina CACS above 316, 636, and 824 correspond to 50%, 80%, and 90% probability of further
testing, respectively. However, higher heart rates and arrhythmias significantly decrease these cutoffs (p < 0.001).
Conclusion CACS significantly increases the ability to identify patients in whom deferral from coronary CTAmay be advised as CTA
does not lead to a final decision regarding CADmanagement. Our results provide individualized cutoff values for given probabilities of
the need of additional testing, which may facilitate personalized decision-making to perform or defer coronary CTA.
Key Points
• Anthropometric parameters on their own are insufficient predictors of downstream testing. Adding parameters of the Diamond
and Forrester pre-test likelihood test significantly increases the power of prediction.
• Total CACS is the most important independent predictor to identify patients in whom coronary CTAmay not be recommended as
CTA does not lead to a final decision regarding CAD management.
•We determined specific CACS cutoff values based on the probability of downstream testing by angina-, arrhythmia-, and heart
rate–based groups of patients to help individualize patient management.
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Abbreviations
AUC Area under the curve
BMI Body mass index
CACS Coronary calcium score
CAD Coronary artery disease
CI Confidence interval
CTA Computed tomography angiography
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Introduction
Coronary CT angiography (CTA) is a gatekeeper to rule out
significant coronary artery stenosis, due to its high sensitivity
and negative predictive value [1–3]. In the 2019 European
Society of Cardiology Guideline for the diagnosis and manage-
ment of chronic coronary syndromes, coronary CTA has a class I
recommendation as the initial test for symptomatic patients in
whom obstructive coronary artery disease (CAD) cannot be clin-
ically excluded [4]. However, in case of irregular heart rate, sig-
nificant obesity, or inadequate breath-hold, coronary CTA is not
suggested since sufficient image quality (IQ) may not be reached
(class III recommendation) [4]. Exact cutoff values for clinical
factors potentially prohibiting sufficient evaluation of CADusing
coronary CTA are scarce. Furthermore, in case of increasing
likelihood of obstructive CAD, coronary CTA may not be the
ideal choice due to the high pre-test probability of significant
CAD [5–9]. However, there is limited information regarding
patient characteristics in whom alternative diagnostic test should
be applied instead of coronary CTA because of high probability
of significant stenosis or foreseeable insufficient IQ of CTA [4].
Coronary calcium score (CACS) correlates with the pres-
ence of obstructive CAD and may also identify extensive cal-
cifications, which may further hamper CTA analysis, due to
partial volume effects and blooming artifacts [10–12].
However, there is minimal data on whether calcium score
values may predict inadequate IQ of coronary CTA.
Therefore, we aimed to assess whether anthropometrics, pa-
rameters of the Diamond and Forrester pre-test likelihood test,
and CACS can predict the need of further testing after coronary
CTA [13]. Further, wewished to provide CACS cutoff values for




We retrospectively included patients who underwent coronary
CTA in our Institution between April of 2016 and September
of 2019 andwhowere reported in a structured reporting platform
(Axis, Neumann Medical Ltd.) with all required clinical, anthro-
pometric, and imaging data allowing convenient export and anal-
ysis of the data. In order to study only patients with suspected
CAD, those with prior invasive or non-invasive testing for CAD
were excluded from our analysis. We also excluded those who
came for CTA of the left atrium and pulmonary veins before
atrial ablation therapy; patients under 18 years; those with
congenital or structural heart disease; those who underwent open
heart surgery or transcatheter valve implantation, or pacemaker
implantation; or those in whom evaluation of the CTA scans was
not possible due to technical issues such as extravasation of
contrast medium. Clinical characteristics and cardiovascular risk
factors were obtained by standardized questionnaires before
examination.
CACS measurement and coronary CTA scan protocol
Coronary CACS and CTA examinations were performed on a
256-slice scanner (Brilliance iCT 256, Philips Healthcare) with
prospective ECG-triggered axial acquisition mode. For CACS,
we used 120-kV tube voltage with 30–50-mAs tube current,
and for coronary CTA 100–120 kV with 200–300-mAs tube
current depending on patient anthropometrics. Image acquisi-
tion was performed with 128 × 0.625-mm detector collimation,
and 270-ms gantry rotation time. For heart rate control, a max-
imum of 50–100 mg metoprolol was given orally and 5–20 mg
intravenously, if necessary. In patients with a heart rate of < 80/
min, mid-diastolic triggering was applied with 3–5% padding
(73–83% of the R-R interval), and in those with ≥ 80/min,
systolic triggering was chosen (35–45% of the R-R interval).
Iomeprol contrast material (Iomeron 400, Bracco Imaging Ltd.)
was used with 85–95 ml contrast agent at a flow rate of 4.5–
5.5 ml/s from antecubital vein access via 18-gauge catheter
using a four-phasic protocol [14]. Bolus tracking in the left
atrium was used to obtain proper scan timing. 0.8 mg sublin-
gual nitroglycerin was given between the CACS and coronary
CTA examinations. Non-contrast data sets were reconstructed
with a slice thickness and increment of 2.5 mm, while coronary
CTA data sets were reconstructed with 0.8-mm slice thickness
and 0.4-mm increment.
CACS was measured by a commercially available semi-
automated software (HeartBeat-CS, Philips IntelliSpace Portal,
Philips Healthcare). Coronary CTA examinations were evaluat-
ed by axial, multiplanar, and curved multiplanar reconstructions
using commercially available software (Comprehensive Cardiac
Analysis, Philips IntelliSpace Portal, Philips Healthcare). All
examinations were evaluated physicians with level 3 or equiva-
lent certification for coronary CTA. Luminal stenosis were clas-
sified into 6 groups: (1) normal—no luminal stenosis; (2) min-
imal—< 25% stenosis; (3) mild—25–49% stenosis; (4) moder-
ate—50–69% stenosis; (5) severe—70–99% stenosis; and (6)
occluded and were reported in a segment-based fashion into a
structured reporting platform (Axis, Neumann Medical Ltd.)
based on the guidelines of the Society of Cardiovascular
Computed Tomography [15].
Outcome definitions
We aimed to study the influence of the various clinical param-
eters and CACS on the need for additional testing of CAD
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after coronary CTA. Therefore, we determined Outcome 1 as
the need for further testing following coronary CTA due to
inadequate IQ (non-diagnostic IQ of at least one coronary
segment) and/or the presence of obstructive CAD (at least
50% luminal stenosis on any coronary on CTA). We did fur-
ther sub-analyses to determine the cause of downstream test-
ing. We determined Outcome 2 as non-diagnostic IQ of coro-
nary CTA (in at least one coronary segment); and Outcome 3
as presence of at least 50% luminal stenosis on coronary CTA
as these stenoses may be hemodynamically significant [16].
Model specifications
For all three outcomes, we built the following models.Model
1, clinical factors routinely evaluated during coronary CTA:
body mass index (BMI), heart rate at scan, and any heart
rhythm irregularity (sinus vs irregular) at scan which may
reduce coronary CTA IQ. Model 2, parameters of Model 1
and characteristics of the Diamond and Forrester score used
to asses pre-test probability of obstructive CAD: age, sex, and
type of angina (typical, atypical, non-specific) [13]. Model 3,
parameters ofModel 2 including also CACS using categories
of 0, 1–10, 11–100, 101–400, 401–1000, and > 1000 [17].
Statistical analysis
Continuous variables are expressed as mean ± SD while cat-
egorical variables are expressed as frequencies and percent-
ages. We performed multivariate logistic regression and re-
ceiver operating characteristics (ROC) analyses to examine
the influence of the various factors (Models 1–3) on down-
stream testing following coronary CTA (Outcome 1) and also
sub-analyses for the cause of downstream testing: inadequate
IQ (Outcome 2) or the presence of at least 50% luminal ste-
nosis on coronary CTA (Outcome 3). We calculated the R2
using the Nagelkerke method for the logistic regression
models to enumerate the variation accountable to the investi-
gated parameters. Sensitivity, specificity, positive and nega-
tive predictive values, and accuracy were derived from ROC
analysis using Youden index. We compared the areas under
curves (AUCs) for the abovementioned models using the
DeLong’s test [18]. Finally, we conducted a simulation anal-
yses, where we predicted the probability of further down-
stream testing for subgroups of the significant predictors of
Outcome 1. For this, CACS was included as a continuous
variable to allow reporting of exact CACS cutoff values for
specific probabilities. All analyses were done in the R envi-
ronment (version: 3.6.1) [5]. ROC analyses and R2 values
were calculated using the ‘pROC’ (version: 1.15.3) and ‘rsq’
(1.1) packages respectively [6, 7]. Two-tailed p values smaller
than 0.05 were considered significant.
Results
Patient characteristics
We included 6705 patients who underwent coronary CTA due to
suspected CAD. One thousand one hundred fifty-eight patients
were excluded due to known prior CAD, 1160 CTA scans due to
imaging of the left atrium and pulmonary veins before atrial
ablation therapy. Furthermore, 267 patients were excluded due
to the presence of congenital or structural heart disease, and
pacemaker electrodes, and due to any other indication of cardiac
CTA. After exclusion, the final number of analyzed patients was
4120 (45.7% female, 57.9 ± 12.1 years). The mean BMI of the
patients was 28.4 ± 7.7 kg/m2, and mean heart rate was 59.9 ±
9.1 bmp. Arrhythmia was present in 152 patients (3.7%).
Detailed data on the cardiovascular risk factors and coronary
CTA scan parameters are in Table 1. Altogether, 275 (6.7%) of
the coronary CTA scans were non-diagnostic in at least one
coronary segment. The main reasons for inadequate IQ were
motion artifact (248/275, 90.2%), image noise (51/275, 18.5%),
and heavy calcification (49/275, 17.8%). Obstructive (> 50%
stenosis) coronary artery stenosis was detected in 1073/4120
(26.0%) of the included patients. In 1236/4120 (30.0%) of pa-
tients, downstream testing was suggested either because of non-
Table 1 Demographic data
Patient characteristics Overall (n = 4120)
BMI (kg/m2) 28.4 ± 7.7
Frequency (beats/min) 59.9 ± 9.1
Heart rhythm irregularity, n (%) 152 (3.7)
Age (years) 57.9 ± 12.1
Female, n (%) 1884 (45.7)










> 1000 195 (4.7)
Hypertension, n (%) 2434 (59.1)
Diabetes mellitus, n (%) 614 (14.9)
Hyperlipidemia, n (%) 1640 (39.8)
Current or former smoker, n (%) 1246 (30.2)
Dose length product (mGy × cm)
For CACS 33.2 ± 15.4
For coronary CTA 285.9 ± 94.7
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diagnostic IQ or because of the presence of > 50% of stenosis on
other coronary segments.
Factors contributing to the need for downstream
testing following coronary CTA
Anthropometric parameters (Model 1) achieved weak diagnostic
accuracy to identify patients referred to further testing (AUC=
0.56 [0.54–0.58]). Including parameters of the Diamond and
Forrester score (Model 2) significantly improved the discrimina-
tory power (AUC= 0.72 [0.70–0.74]; p < 0.001). Adding CACS
(Model 3) further increased the diagnostic accuracy (AUC= 0.84
[0.83–0.86]; p < 0.001 compared to Model 1 and Model 2).
Sensitivity, specificity, positive and negative predictive values,
and accuracy of the models were the following: 39.1%, 72.5%,
73.9%, 73.5%, and 62.5% for Model 1; 65.4%, 68.4%, 47.0%,
82.2%, and 67.5% for Model 2; and 69.9%, 83.8%, 64.9%,
86.7%, and 79.6% for Model 3, respectively. Results are sum-
marized in Fig. 1.
In our final model, each additional beat per minute during the
examination increased the odds of downstream testing by 1.03
(p< 0.001), the presence of any kind of heart rhythm irregularity
by 2.12 (p < 0.001), atypical and typical angina by 1.29 and 1.64
(p < 0.01; p < 0.001; respectively), and CACS categories by
CACS1–10: 2.46; CACS11–100: 4.23; CACS101–400: 12.34;
CACS401–1000: 33.83; and CACS>1000: 164.90 (p < 0.001 for
all). Detailed results can be found in Table 2.
Factors contributing to non-diagnostic image quality
resulting in additional testing following coronary CTA
Adding risk factors (Model 2) and total CACS (Model 3) to
anthropometric factors (Model 1) did not improve significant-
ly the discriminatory power of finding non-diagnostic IQ of at
least one coronary artery segment (AUC = 0.79 [0.78–0.83]
for Model 1; AUC = 0.80 [0.78–0.83] for Model 2; AUC =
0.80 [0.78–0.83] for Model 3; all p > 0.05). Sensitivity, spec-
ificity, positive and negative predictive values, and accuracy
of the models for non-diagnostic IQ were the following:
67.3%, 81.9%, 21.0%, 97.2%, and 80.9% for Model 1;
69.5%, 79.2%, 19.2%, 97.3%, and 78.6% for Model 2;
77.5%, 70.4% 15.8%, 97.8%, and 70.9% for Model 3.
Results are summarized in Fig. 1.
After adjustment for Model 3, each extra beat per minute
increased the odds of insufficient IQ by 1.07 (p < 0.001), ir-
regular heart rhythm by 2.70 (p < 0.001), and CACS groups
by CACS11–100: 1.53; CACS101–400: 2.07; CACS401–1000:
2.59; and CACS>1000: 3.11 (p < 0.05 for all), while male sex
decreased the odds of inadequate IQ by 0.54 (p < 0.001).
Detailed results can be found in Supplementary Table 1.
Factors contributing to the presence of significant
stenosis resulting in further testing following
coronary CTA
Anthropometric parameters (Model 1) proved to be insuffi-
cient in the discrimination of those with obstructive coronary
artery stenosis (AUC = 0.56 [0.54–0.58]). Addition of the age,
sex, and type of chest pain (Model 2) resulted in significantly
higher diagnostic accuracy (AUC = 0.74 [0.72–0.75];
p < 0.001). Adding total CACS (Model 3) further improved
diagnostic power (AUC = 0.87 [0.86–0.88]; p < 0.001). For
significant coronary artery stenosis, as the outcome, sensitiv-
ity, specificity, positive and negative predictive values, and
accuracy of the models were the following: 64.1%, 45.0%,
29.1%, 78.1%, and 50.0% for Model 1; 75.9% 60.6%,
40.4%, 87.7%, and 64.6% for Model 2; and 77.2% 82.3%
60.6%, 91.1%, and 81.0% for Model 3.
In the final model, each year of age increased the odds of
significant coronary artery lesion by 1.01 (p = 0.04), male sex
Fig. 1 ROC curves of the various models for identifying those who need downstream testing, because of non-diagnostic IQ and/or the presence of
significant coronary artery stenosis. Abbreviations: BMI, body mass index; CACS, coronary calcium score; HR, heart rate; IQ, image quality
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by 1.22 (p < 0.01), atypical and typical chest pain by 1.36 and
2.00 (p < 0.001), and coronary artery calcification by CACS1–
10: 4.03; CACS11–100: 7.22; CACS101–400: 22.16; CACS401–
1000: 60.34; and CACS>1000: 326.75 (p < 0.001 for all).
Detailed results can be found in Supplementary Table 1.
Probability of downstream testing for specific CACS
thresholds for given heart rates, presence
of arrhythmia, and type of chest pain
In our analysis of additional testing for any reason after coro-
nary CTA (Outcome 1), type of chest pain, heart rate, and
presence of heart rhythm irregularity proved to be independent
predictors of further testing of CAD beyond total CACS. We
simulated the probability of downstream testing for given
CACS values for patient groups with non-specific, atypical
and typical angina, sinus rhythm, or arrhythmia with heart rate
of 50–60–70–80–90 bpm separately. Probability plots are pre-
sented in Fig. 2, while CACS cutoff values for specific prob-
abilities of further testing are presented in Table 3.
Discussion
Our results indicate that anthropometric parameters on their own
are insufficient to identify patients in whom additional testing of
CAD after coronary CTA is highly probable. Classical risk fac-
tors of the Diamond and Forrester pre-test probability score gave
additional power to the prediction. However, inclusion of total
CACS significantly improved the diagnostic accuracy providing
excellent discriminatory power to identify patients by whom de-
ferral of coronary CTAmay be recommended as a final diagnos-
tic decision regarding CAD could not be made. In case of non-
specific angina, CACS above 435, 756, and 944; in atypical
angina CACS above 381, 702, and 890; and in typical angina
CACS above 316, 636, and 824 correspond to 50%, 80%, and
90% probability of further testing for patients with sinus rhythm
of 50 bpm. However, higher heart rates, and presence of heart
rhythm irregularity, significantly decrease these cutoffs
(p < 0.001); therefore, strict heart rate control is still advised.
Our results provide individualized cutoff values for given prob-
abilities of downstream testing, which may help personalize
decision-making in whom alternative tests may be beneficial as
coronary CTA does not lead to a final clinical decision. Future
prospective studies are warranted to assess the effect of applying
CACS as a gatekeeper for coronary CTA on patient management
and outcomes and also on the healthcare system.
One of the new recommendations of the European Society
of Cardiology in 2019 is the endorsement of coronary CTA as
an initial non-invasive test for those by whom clinical assess-
ment alone is not enough to rule out obstructive CAD [4].
These recommendations follow previous initiatives of the
Table 2 Multivariate logistic regressionmodels for predicting downstream testing (Outcome 1). Abbreviations: BMI bodymass index;CACS coronary
calcium score; OR odds ratio
Outcome: downstream testing
Model 1 Model 2 Model 3
OR 95% CI p value OR 95% CI p value OR 95% CI p value
BMI 1.01 1.00–1.02 0.02 1.01 1.00–1.02 0.11 0.99 0.98–1.00 0.22
Frequency 1.01 1.00–1.02 < 0.01 1.02 1.01–1.03 < 0.001 1.03 1.02–1.04 < 0.001
Rhythm Sinus Reference Reference Reference
Irregular 2.70 1.93–3.81 < 0.001 1.76 1.22–2.56 < 0.01 2.12 1.39–3.23 < 0.001
Age 1.07 1.06–1.08 < 0.001 1.01 1.00–1.02 0.06
Sex Female Reference Reference
Male 2.00 1.72–2.33 < 0.001 1.02 0.85–1.23 0.80
Angina Non-specific Reference Reference
Atypical 1.15 0.99–1.34 0.07 1.29 1.08–1.54 < 0.01
Typical 1.69 1.33–2.15 < 0.001 1.64 1.24–2.17 < 0.001
CACS 0 Reference
1–10 2.46 1.70–3.53 < 0.001
11–100 4.23 3.31–5.42 < 0.001
101–400 12.34 9.56–15.99 < 0.001
401–1000 33.83 24.43–47.29 < 0.001
> 1000 164.90 91.20–325.50 < 0.001
R2 0.021 0.169 0.423
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National Institute of Health and Care Excellence in the UK,
where coronary CTA is recommended as the initial diagnostic
test in stable chest pain patients [9]. In compliance with the
guidelines, it is prognosticated that a 700% increase in coro-
nary CTA delivery is required in the UK alone [4]. In order to
decrease the burden of the healthcare systems, identification
of patients in whom coronary CTA does not lead to a final
diagnostic decision-may be needed, as these patients may ben-
efit more from alternative tests.
When analyzing the predictors of further testing of CAD,
heart rate, presence of heart rhythm irregularity, type of chest
pain, and coronary artery calcium were all significant inde-
pendent predictors. From all these factors, coronary calcifica-
tion was by far the most prominent predictor (OR = 33.83 for
CACS401–1000 and OR = 164.90, for those with CACS>1000).
These results were mainly driven by the ability of CACS to
predict obstructive CAD which needs further testing or inter-
vention, as in our sub-analysis predicting non-diagnostic IQ,
the model with simple anthropometric parameters had the
same diagnostic accuracy as more complex models incorpo-
rating risk factor and CACS.
Coronary artery calcification has been reported to be an
important predictor of significant coronary artery stenosis
[10, 19–22]. Until now, only some risk-predicting score sys-
tems such as the Multi-Ethnic Study of Atherosclerosis risk
score implanted CACS into their models, even though a recent
study reported that CACS is the most important predictor of
CAD-related outcomes [23]. Our results are in line with these
findings, since beyond age, male sex, and type of chest pain,
CACS proved to be the most prominent predictor of obstruc-
tive coronary artery stenosis as depicted by coronary CTA
(OR = 60.34 for those with CACS401–1000 and OR = 326.75
for CACS>1000). These results indicate that routine assessment
of CACS before coronary CTAmay allow the identification of
patients in whom coronary CTA alone may be not enough for
the evaluation of CAD, as in these cases the probability of
finding at least 50% lumen stenosis potentially being
hemodynamically significant and therefore needing further
assessment is very high.
Coronary artery calcification may also cause blooming and
beam-hardening artifacts resulting in a virtual increase of the
plaque volume, and therefore leading to the overestimation of
the stenosis and increase of false positive results [12, 24].
Several studies investigated the influence of CACS on the
accuracy of coronary CTA. Most of them reported a CACS
score > 400 as a threshold for prominent decrease in diagnos-
tic accuracy [7, 25–32]. However, all of them used 64-slice or
dual-source CT. Based on our results, in case of a 256-slice CT
scanner, CACS did not prove to have additional role in the
prediction of insufficient IQ. Above CACS, higher heart rate
and arrhythmia were important contributors of insufficient IQ,
since in 90.2% of the cases non-diagnostic IQ was due to
motion artifact. Moreover, after adjustment for the main car-
diovascular risk factors and CACS, heart rate (OR = 1.07),
and arrhythmia (OR = 2.70), proved to be important predictors
of non-diagnostic IQ. Even though 256-slice CTscanners per-
mit better partial and temporal resolution, rhythm control and
optimal heart rate are still important for achieving diagnostic
IQ in all coronary artery segments.
Our simulation results revealed that no single CACS cutoff
can be provided as the type of chest pain, arrhythmia, and
heart rate all significantly change the probability of requiring
further downstream testing either because of insufficient IQ or
because of presence of significant stenosis. Our tables may
help the decision-making at an individual level.
Our study has some limitations. First of all, it is a single-
center, retrospective study using only one vendor system; there-
fore, our results are only generalizable to other populations and
other machinery with caution. Second, we have no information
on the results of downstream testing. However, our aim was not
to assess the diagnostic accuracy of coronaryCTA, since the high
sensitivity and negative predictive value of this modality are
already well-known, but to assess in whom coronary CTA may
not be beneficiary as it does not lead to a final diagnostic
Fig. 2 Probability plot of downstream testing following coronary CTA by type of angina, heart rhythm regularity, heart rate, and total CACS.
Abbreviations: CACS, coronary calcium score; HR, heart rate
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decision. Third, fractional flow reserve analysis of the CTA im-
ages was not done, which could have decreased the referrals to
further testing. However, most centers do not have access to this
technology yet and therefore fractional flow reserve-based out-
comes would limit the generalizability of the results. Finally, it is
a single-vendor study; therefore, the effect of anthropometrics
might be different on other machines.
In conclusion, routine evaluation of CACS before coronary
CTA may be advised as it significantly increases the diagnos-
tic accuracy to identify patients in whom further testing will be
needed following coronary CTA. Deferral of these patients to
other diagnostic modalities might be beneficial as coronary
CTA does not lead to a final decision regarding CAD
management.
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